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• Demonstrate upper quartile leadership in
clinical excellence to our patients, referring
physicians, as well as regulatory and
reviewing organizations. A sampling of our
benchmark reports for breast, prostate and
head and neck cancer quality outcomes are
found in this report.
• Improve the patient care experience
including the addition of a lung care
coordinator, survivorship programming,
expedited response to phone calls, and
transportation assistance.
• Ensure critical cancer specialists are available
to meet increasing demands of the region is of
utmost importance. Staff additions for
physicians, registered nurse coordinators, and
several support areas are in process.
• Assure patients have access to leading edge
treatment and technologies have resulted in
multiple program development priorities.
• Implementing new radiation programs such
as partial breast irradiation;
• Opening additional research studies to offer
more patients cutting-edge treatment options
close to home;
Being involved in leading and developing cancer services is
exciting. We believe the challenges before us have never been
more complex; but never more important.
During the past eighteen months the Cancer Center Board, with support from organizational
and community executives, patients and physicians, focused on completing a thorough
assessment of our cancer program. We worked with an outside consultant to assess current
strengths and opportunities while also evaluating how well we are positioned to meet future
challenges as Central Minnesota’s comprehensive regional cancer program of excellence.
We concluded this appraisal with confidence that CentraCare is poised to meet the region’s
needs for cancer care; a conclusion simultaneously echoed by two national accreditation
bodies — Commission on Cancer and American College of Radiology.
St. Cloud Hospital has an award winning cancer program gaining recognition as a quality
cancer care provider in Central Minnesota and beyond. But just as we are energized by
being able to practice at a time when great cancer advances are happening literally
everyday, we cannot rest on today’s successes.
Coborn Cancer Center goals:
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• Adding several newly approved chemotherapy options;
• Participating in regional program development through a three-
hospital cooperative effort to provide cancer patients in Monticello
with new cancer access by the fall of 2008.
When cancer can be prevented or detected early the cancer program
celebrates along with the communities we serve. Early detection
markedly increases available treatment options, minimizes side effects
and improves chances for long term survival. Much of the work to
prevent and/or find cancer early happens before individuals are ever
patients at Coborn Cancer Center. In Central Minnesota there are
hundreds of well trained and committed physicians and health care
professionals who are working daily to educate and screen for cancer.
If it were not for the diligence of the people living in Central
Minnesota working in close collaboration with their primary health
care providers, the work of the Cancer Center would be much more
challenging. On behalf of the Cancer Center, we applaud your efforts
and remain committed to our mutual partnership to remove the
diagnosis of cancer from our lives.
Jo Zwilling, R.N., M.B.A.
Cancer Center Director
Nicholas F. Reuter, M.D., F.A.C.P.
Cancer Center Medical Director
Coborn Cancer Center is proud to
be a department of St. Cloud
Hospital and is equally proud to
provide the same high-quality care
that St. Cloud Hospital has been so
highly awarded for. St. Cloud
Hospital’s national recognition for
outstanding care includes:
• Magnet Award for Excellence in
Nursing (2004-2008)
• A Thomson Top 100 Hospital
(1993, 1994, 1999, 2005, 2006 and
2007)
• An “America’s Best Hospital”
U.S. News &World Report (2005,
2006 2007 and 2008)
“I had the option to go to Mayo, but St. Cloud has the same
level of care — my treatment would have been the same. I never doubted
staying in St. Cloud for my care.” | Carol Rupp, 10-year breast cancer survivor
Carol Rupp was diagnosed with stage one breast cancer in 1998 during a routine mammogram.
Carol endured a battery of surgery, chemotherapy, radiation and hormone therapy.
Today Carol testifies how having comprehensive services, right in St. Cloud,
can impact the journey for a cancer patient and their family.
Achievements
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This report will discuss the local treatment options
and outcome for early stage I and II breast cancer.
In 2007, there were 272 breast cancer cases
diagnosed and/or treated at St. Cloud Hospital
(SCH), Coborn Cancer Center and/or CentraCare
Radiation Oncology at Douglas County Hospital
(in Alexandria). Of these 272 cases, 271 were
female. The percentage of stage I and II female
breast cancer cases was 41% and 28%
respectively which is comparable to the National
Cancer Data Base (NCDB). See table 1.
Most women have no symptoms but are found to
have an abnormality on screening mammogram.
The most common histology in both the SCH 2007
cases and National Cancer Data Base is infiltrating
ductal carcinoma. Five-year survival rates at
St. Cloud Hospital exceed the NCDB rates at 95%
for stage I and 88% for stage II compared to
national figures of 91% and 82%.
See table 2.
Early diagnosis of breast cancer provides
women with more treatment options. To
enhance diagnostic capablities digital
mammography is now availabe through St.
Cloud Hospital. The recent National Institute
of Health report indicates that the preferred
standard treatment for early stage breast
cancer is breast conserving therapy which
involves a lumpectomy followed by radiation.
There are some patients with stage I or II breast
cancer that may require or desire mastectomy.
Both procedures result in equivalent survival
rates with the former preserving the breast.
CANCER REPORT
Barbi Kaplan-Frenkel, D.O.
FEMALE BREAST CANCER CASES BY AJCC STAGE


























It has been several years since the cancer report has focused on invasive
breast carcinoma. There have been significant advances in the local
regional treatment of breast cancer in recent years. The American Cancer
Society estimates that more than 178,000 women nationwide and 3,200
in Minnesota were diagnosed with breast cancer in 2007 and more than
63% will be diagnosed when the disease is still localized.
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In 2007, there were 221 stage 0-II female breast
cancer cases. Of those, 125 or 57% chose breast
conserving treatment with 97% of these patients
going on to receive radiation therapy at our center.
Nationally, close to 20 percent of patients who
choose lumpectomy for their treatment do not receive
the recommended radiation therapy after their
surgery.
Whole breast irradiation has become the standard of
care after breast conserving surgery because it results
in very low local recurrence rates and low rates of
side effects to normal tissue which result in good to
excellent cosmetic results. Despite these benefits,
however, many women eligible for breast conserving
therapy do not receive it. Women identify a number
of reasons for choosing mastectomy. While some
women choose mastectomy to avoid radiation most
have other concerns about treatment length and travel
burden associated with conventional daily radiation
therapy. Omission of radiotherapy is associated with a
three-fold increase in local tumor recurrence.
During the past ten years, accelerated
partial breast irradiation (APBI) has
been investigated as an alternative to
conventional treatment. In contrast to
standard radiation to the whole breast,
APBI delivers radiation for just one
week and only exposes the breast
tissue at greatest risk of recurrence to
the treatment while limiting radiation
dose to sensitive normal tissues which
surround the breast. The most widely
used form of APBI is MammoSite
5-Day Targeted Radiation Therapy which uses a
balloon catheter to deliver radiation. The Coborn
Cancer Center treated 17 cases of breast cancer with
APBI using the MammoSite catheter in 2007, the first
year of its use in Central Minnesota. We actively
enroll patients into the National Cancer Institute
sponsored study to further define the role of APBI for
early stage breast cancer. The National Surgical
Adjuvant Breast and Bowel Project/ Radiation Therapy
Oncology Group (NSABP/RTOG) randomized trial is
comparing standard whole breast irradiation to partial
breast irradiation.
The technical advances in local regional treatment of
early stage breast cancer followed by adjuvant
treatment of chemotherapy and/or hormonal
manipulation with Tamoxifen or Arimidex offered by
the experienced, multidisciplinary medical team of St.
Cloud surgeons, radiologists, pathologists and Coborn
Cancer Center medical and radiation oncologists has
provided the ability for more women of Central
Minnesota to receive preferred treatment while
maintaining excellent cosmetic results, reduced side
effects, and excellent survival.
FIVE YEAR OBSERVED BREAST CANCER SURVIVAL RATES* 



























* There was an insufficient number of stage IV cases for St Cloud Hospital to calculate the stage IV survival rate
Source: Commission on Cancer, American College of Surgeons, NCDB Survival Reports
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The four most commonly diagnosed
cancers reported by the cancer registry
remains the same as in 1986, breast,
colorectal, lung and prostate. This is in
accordance with national statistics for
site incidence. See table 5.
Excluding skin cancer, breast cancer
remains the most commonly diagnosed
cancer for women in the United States.
In 2007 we saw our largest number,
272 breast cancer cases or 17% of our
total cancer cases, this compared to
the 70 cases reported with the 1986
data. The majority of breast cases,
82%, were diagnosed in early stage (0-
II). See table 4. As new technology and
treatment standards for breast cancer
steadily evolved over the past decade,
the cancer program has been fortunate
to have a dedicated breast center to
educate and improve breast care for
the women of Central Minnesota.
Analysis of 2007 Activity Report
2007 ACTIVITY REPORT
2005 2006 2007
Analytic Cancer Cases¹ 1,376 1,466 1,608
Cases in the Cancer Registry 13,776 14,339 16,045
Cases in Follow-Up 7,306 8,481 9,516
Hospital Discharges 24,932 25,763 26,568
Inpatient Cancer Discharges 1,347 1,589 1,687
Total Cancer Patient Days 6,620 7,627 8,129
Average Length of Stay 4.9 4.8 4.8
(Cancer Patient)
Radiation Therapy Patients Treated 829 775 723
(576 SCH²) (533 SCH²) (492 SCH2)
(253 Alex³) (242 Alex³) (231 Alex3)
Hospice Cancer Patients 129 136 150
# of Cases Presented at 224** 194** 178**
Cancer/Breast Conference
Average # of Physicians Attending 9 7 9
Weekly Cancer Conference
¹Cases diagnosed and/or received their first course of therapy at St. Cloud Hospital/Coborn Cancer Center/
CentraCare Radiation Oncology at Douglas County Hospital, Alexandria.
²SCH refers to St. Cloud Hospital
³Alex is CentraCare Radiation Oncology at Douglas County Hospital, Alexandria
*In 2004, the cancer registry changed its reference date from 1986 to 1994
**Breast Conference cases and attendance are included in this figure starting in 2003.
Writing this 2007 activity report is exciting and revealing. First of all the
tremendous growth and expansion of our cancer program in Central
Minnesota is evident in the numbers. The first St. Cloud Hospital cancer
report was published by the cancer registry in 1987 and revealed 574
cases diagnosed and/or treated by the cancer program in 1986. Compare
this to the 1,608 cases diagnosed and/or treated in 2007 and there is
evidence of the tremendous growth, commitment, and accomplishments
of the St. Cloud Hospital cancer program. See table 3.
TABLE 3
Mark Hauge, M.D.
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Prostate cancer is the most frequently diagnosed cancer in men both
nationally and in our community. More than 90% of all prostate cancers are
diagnosed in the local or regional stages leading to a 5-year relative survival
rate of almost 100%. For the 291 cases reported in 2007, 89% were
diagnosed in early stage (0-II). See table 4. Since 2004 the Coborn Cancer
Center has partnered with Adult & Pediatric Urology, P.L.L.P. to identify and
measure quality and outcomes of prostate cancer care for our patients. More
information is available on our website www.centracare.com.
Lung cancer accounts for about 15% of cancer diagnoses in the nation.
Likewise lung cancer represents 14% of our total cancer cases for 2007 with
a total of 226 cases accessioned by the registry. Unfortunately the majority of
lung cases continue to be diagnosed at later stages (III and IV). This holds true
with 65% of our cases and is congruent with national statistics. See table 4.
Because survival depends upon the disease being diagnosed while still
localized; the emphasis and hope for the future depends upon new
technology that will provide early detection. Study results for a large multi-
sponsored clinical trial assessing screening of high-risk individuals with spiral
CT or standard chest X-ray are expected to be reported by 2010.
Nursing Staff Achievements
Currently 70 percent of
registered nurses at Coborn
Cancer Center hold national
specialty certificates.
Achievements
SITE In-situ I II III IV UNKNOWN N/A** TOTAL
ALL CASES 111 345 433 200 250 110 159 1608
Breast 37 110 76 30 8 11 0 272
Prostate 0 0 260 19 10 2 0 291
Lung/Bronchus 0 36 8 51 97 31 3 226
Colon/Rectum 36 34 34 27 22 17 5 175
**NA (Not Applicable) refers to cancers that do not have an AJCC staging scheme.
(AJCC) = American Joint Commission on Cancer
TABLE 4
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Achievements
Colorectal cancer is the third most common cancer for men and
women and thus remains one of the top four cancers diagnosed in the
nation and Central Minnesota. There were 175 cases accessioned into
our registry in 2007. Fifty-nine percent of these cases were diagnosed as
early stage (0-II). See table 4. Colorectal cancer rates have been
decreasing over the past two decades, partly due to an increase in
screening, which can result in the detection and removal of colorectal
polyps before they progress to cancer. In addition, new targeted
monoclonal antibody therapies, such as bevacizumab, cetuximab, and
panitumumab, have recently been approved by the Federal Drug
Administration (FDA) to treat metastatic colorectal cancer thus
improving the treatments options.
For the past several years we have reported an upward trend in the
number of kidney and bladder cancers accessioned. This trend
continues with 8% of total (1,608) cases accessioned represented by
these two diseases. The most frequently occurring genitourinary cancers,
(prostate, kidney, and bladder) represent 26% of the cancers diagnosed
and/or treated in our community in 2007. Nationally it is estimated that
these cancers combined will represent 22% of new cancer cases
SITE INCIDENCE OF TOP FOUR CANCER SITES
(Compared to total number of cancers diagnosed)
Site St. Cloud Hospital Minnesota* Nationwide*
Prostate 18% 19% 15%
Breast 17% 13% 12%
Lung/Bronchus 14% 12% 15%
Colon/Rectum 11% 10% 11%
*Minnesota and nationwide statistics taken from the American Cancer Society (ACS) Facts/Figures 2007.
TABLE 5





from the American College
of Radiology. Coborn
Cancer Center is one of
only two programs to
receive this prestigious
recognition.
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diagnosed by the end of 2008.
Recognizing the impact of
these cancers on the lives of
our patients, we have partnered
with Adult & Pediatric Urology,
P.L.L.P. to bring more emphasis
and community awareness to
genitourinary cancer research
studies focused on finding new
and better treatment options.
Without the experienced staff
of the cancer registry it would
be impossible to measure the
growth of the program or to
analyze the outcomes of
treatment and preventative
care. Just as the program
changed since the first cancer
report in 1987, so has the role
of cancer registry. Emphasis
remains on volume but also
includes quality outcomes such
as survival and use and
adherence to clinical practice
guidelines. The registrars have
provided ongoing support for
the cancer team for more than
22 years and are commended
for their hard work and
dedication.
2007 SITE INCIDENCE DATA AT ST. CLOUD HOSPITAL
ALL SITES 2005 2006 2007
Oral Cavity 27 26 47
Tongue 10 5 8
Oropharynx, Hypopharynx 0 2 3
Other 17 19 36
Digestive System 203 216 274
Esophagus 22 17 20
Stomach 6 12 21
Colon 98 107 126
Rectum, Rectosigmoid 35 33 49
Anus/Anal Canal 3 0 7
Liver & Bile Ducts 6 2 7
Pancreas 18 27 34
Other 15 18 10
Respiratory System 203 197 241
Larynx 9 11 9
Lung/Bronchus 193 180 226
Other 1 6 6
Hematopoietic/Lymphoid 125 150 141
Leukemia 31 31 35
Multiple myeloma 10 21 15
Other hematopoietic 15 27 21
Hodgkin lymphoma 6 12 9
Non-Hodgkin lymphoma 63 59 61
Bone 1 4 4
Connective/Soft Tissue 5 5 4
Skin 29 29 45
Melanoma 27 26 44
Other 2 3 1
Breast 266 255 272
Female Genital 45 51 42
Cervix Uteri 3 2 6
Corpus Uteri 33 34 20
Ovary 7 14 16
Other Female 2 1 0
Male Genital 231 265 302
Prostate 214 257 291
Testis 14 6 9
Other Male Genital 3 2 2
Urinary 129 150 137
Bladder 65 70 65
Kidney/Renal 61 75 69
Other Urinary 3 5 3
Brain and CNS 38 37 36
Brain (Benign) 0 1 1
Brain (Malignant) 17 20 19
Other Brain and CNS 21 16 16
Endocrine 55 49 39
Thyroid 46 41 34
Other 9 8 5
Unknown Primary 16 22 21
Other/Ill-Defined 3 10 3
TOTAL 1376 1466 1608
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Research programs within the Coborn Cancer Center are
North Central Cancer Treatment Group (NCCTG), Mayo
Clinic Cancer Research Consortium (MCCRC), Radiation
Therapy Oncology Group (RTOG), National Surgical
Adjuvant Breast and Bowel Project (NSABP) and active
participation in Cancer Trial Support Unit (CTSU)
expanding our access to cancer studies.  
The St. Cloud Hospital Institutional Review Board ensures
the activities of the research department at Coborn Cancer
Center are ethical and appropriate.  
We have numerous clinical trials open expanding
treatment options for patients and physicians fighting the
cancer battle. For a complete listing of cancer studies
available visit www.centracare.com. 
In addition to clinical trials we have available at the
Coborn Cancer Center, we are able to help patients find
out if there are other research options available anywhere
in the nation to treat their disease. 
Achievements
Relay for Life
The staff at Coborn Cancer Center
collaborates with many partners in the
region to bring awareness, early detection
and education to the people of Central
Minnesota through events such as the
local Relay for Life. Coborn Cancer Center
is proud to be a Relay for Life lead sponsor
in these communities: St. Cloud,
Alexandria, Becker, Cold Spring,
Glenwood, Little Falls, Long Prairie,
Melrose, Paynesville and Sauk Centre. 
The pace of new cancer drug development continues to
accelerate as well as the ever-changing process and method
for delivering radiation therapy, another staple of cancer
treatment. The Coborn Cancer Center is committed to
providing cancer patients access to the newest and best
research protocols.  
Research
Sandy Johnson,, R.N., A.O.C.N.S.
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Physicians Published
Drs. Nicholas Reuter and Harold
Windschitl, medical oncologists
at Coborn Cancer Center, were
published in the 2008 American
Society of Clinical Oncology
(ASCO) Annual Meeting
Proceedings Supplement to
Journal of Clinical Oncology.
Nicholas F. Reuter, M.D.
published Comparison of
progression-free survival with
best or confirmed response as an
endpoint for overall survival in
advanced non-small cell lung
cancer. A North Central Cancer
Treatment Group (NCCTG)
investigation. 
Harold E. Windschitl, M.D.
published Effect of intravenous
calcium and magnesium on
oxaliplatin-induced sensory
neurotoxicity in adjuvant colon




Peggy Weber, 36, had been married for two years. While
building their life together, she and her husband learned the
shocking diagnosis — Peggy had stage III breast cancer. The
newlyweds teamed up for their battle against cancer. What
Peggy soon learned, and came to rely on, was the team she
had working for her. 
“The staff, case coordinators and doctors were awesome. 
No matter whom I saw — my oncologist, psychologist,
surgeon, etc… — everyone knew where I was in my treatment
and how I was doing. I had such a great team.
I couldn’t ask for a better group of people.” 
| Peggy Weber, two-year breast cancer survivor
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BREAST CANCER CARE 
Quality Indicator Measure St. Cloud Hospital1 National2
Our Story of Quality
Quality indicators are specific data measures that describe national or local benchmarks
and goals set for the cancer program. There is no mandate or national cancer quality
monitoring system for cancer programs to measure their quality of care but there is a
growing interest in efforts to assess quality. Since late 2004, the Coborn Cancer Center
has embarked on a cutting-edge undertaking to assess the quality of care delivered by
our cancer program. We’d like to share some of our findings with you.
1 St. Cloud Hospital Cancer Registry: 2006 data    
2 Oncology Roundtable 2004 Benchmarking Clinical Quality 
Having expert breast radiologists doing breast biopsy using stereotactic or ultrasound technology reduces the
number of women who must have surgery to make a diagnosis.  With an experienced team of surgeons using
sentinel node biopsy we can prevent unnecessary lymph node dissections and subsequent risk of life-long
complications.
Use of minimal invasive Percent of patients 97% 50% technology for biopsy receiving stereo or 
ultrasound biopsy 
versus surgical biopsy
Time to diagnosis Average time from 1.7 days 3.5 days biopsy to diagnosis
Sentinel node biopsy Percent of eligible 100% 100% patients that had if technology is 
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1 St. Cloud Hospital Cancer Registry: 2004-2006 cases    
2 National Cancer Data Base, Commission on Cancer, ACOS Benchmark Report 2000-2005 data 
Outstanding prostate cancer care is available in our community due to the close collaboration of specialists
including: urologists, pathologists, and radiation and medical oncologists.  
1 St. Cloud Hospital Cancer Registry: 2001-2005 data    
2 National Cancer Data Base Commission on Cancer, ACOS Benchmark Report 2001-2004 data
A diagnosis of oral or larynx cancer requires a multidisciplinary approach of specialists which may include an
oral surgeon, ear/nose/throat surgeon, medical oncologist, radiation oncologist, prosthodontist, general dentist,
plastic surgeon, dietitian, speech therapist, and nurses among other clinicians. 
For more cancer quality care measures visit www.centracare.com/specialty_centers/cancer/quality_measures.html
Early diagnosis Percent of patients 88% 78% diagnosed at early 
Stage (I or II)
Complete pathology reported Percent of pathology 100% 90% reports that contained 
all essential Required by
requirements of Commission on
American College of Cancer
Pathology
Volume of cases Number of cases More than 250 cases Not Available Not 
each year Applicable
PROSTATE CANCER CARE 
Quality Indicator Measure St. Cloud Hospital1 National2
HEAD & NECK CANCER CARE 
Quality Indicator Measure St. Cloud Hospital1 National2
Early diagnosis Percent of patients Larynx 65% Larynx 55% diagnosed at early Oral/Pharynx/Lip 39% Oral/Pharynx/Lip 34%
Stage (0-II) 
Interruptions in treatment Percent of patients that Larynx 98% Not Available Not
completed planned Oral/Pharynx 85% Applicable
radiation treatment 
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GGenerous Gifts….Changing Lives
A diagnosis of cancer can leave
patients feeling overwhelmed and
alone. Generous gifts have eased the
stress and pain of patients and
families by providing the personal
touch of a nurse care coordinator. The
care coordinator is a patient’s lifeline;
they help patients navigate through
the cancer journey by providing
assistance with appointments,








Deb Corrigan, R.N., lung cancer care coordinator 
pictured with Karen Corbin, lung cancer patient 
With your gifts, we hope to provide disease specific care
coordinators for the top six cancers seen in Central Minnesota.
Your support will give patients and their families the friendship
and support they need during their cancer journey.  
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Aunt Leona Fund
Almeda Ella Pollish Fund
Breast Cancer Greatest Needs Fund
Breast Center Sales Fund
Cancer Survivorship Network Fund
Coborn Cancer Center Endowment Fund
Coborn Cancer Center Greatest 
Needs Fund
Craig & Lynn Dahl Fund
Dr. Harold E. Windschitl Cancer 
Research Fund 
Dr. Nicholas & Bernice Reuter Fund
Hank & Dee Coppock Fund
Hind Site Fund
John & Nancy Frobenius Breast Cancer
Fund
Pat Opatz Cancer Research Fund
Pediatric Cancer Greatest Needs Fund
Quinlivan & Hughes Fund
Radiation Oncology at Douglas 
County Hospital  
(Alexandria) Fund
Surviving with Style Fund
Generous Gifts….
Changing Lives
“From her initial phone
call informing us of the
cancer, through the final
radiation treatment, Julie
was a true blessing to
our family.” Michele Lindmeier
Juli Sanner, R.N., breast cancer care
coordinator pictured with Michele
Lindmeier, breast cancer patient
Cancer Named Funds
Fund-naming opportunities are available for the Coborn Cancer Center.
Our utmost gratitude from the staff, physicians and patients who see
your gifts impact cancer patients every day.
For more information on supporting these funds or creating your
own, please call the Foundation at (320) 240-2810. 
For a list of individual benefactors please visit
www.centracare.com/foundation/benefactors.html. 
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Hani S. Al-Khatib, M.D.,
Hematology/Oncology




Linda Chmielewski, R.N., 
Vice President, Operations
Shawn K. Day, D.O., 
Family Practice
Marc A. Dvoracek, M.D., 
Pathology
Ronald D. Hanson, M.D.,
Otolaryngology
Mark D. Hauge, M.D.,
Hematology/Oncology
Donald J. Jurgens, M.D.,
Hematology/Oncology 
Sandy Johnson, R.N., A.O.C.N.,
Oncology 
Barbi L. Kaplan-Frenkel, D.O.,
Radiation Oncology
Maria D. Mallory, M.D., 
Surgery
Andre L. Mitchell, M.D., 
Radiation Oncology
Derek Peterson, R.N., 
Director, Radiation Oncology
Nicholas F. Reuter, M.D.,
Hematology/Oncology, 
Cancer Center, Medical Director
Jane Vortherms, R.N., 
Director, Chemotherapy and
Oncology Clinic
Roxanne Wilson, R.N., 
Care Center Director 
Inpatient Oncology
Harold E. Windschitl, M.D.,
Hematology/Oncology 
Jo Zwilling, R.N., 
Cancer Program, Director 
Cancer Care Center
BOARD MEMBERS
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1900 CentraCare Circle | St. Cloud, MN 56303
www.centracare.com
Achievements
Coborn Cancer Center received
three-year approval with
Commendation and an Outstanding
Achievement Award as a
Comprehensive Community Cancer
Program from the American College
of Surgeons Commission on
Cancer. This is the highest level of
achievement and has been earned
only about 15 percent of cancer
programs in the nation.
A Reflections by Eden Zimny
The cover painting on this report was inspired by
Eden, while watching her mother go through
cancer treatments and surgery. Eden says, “To me
this painting represents the emotional and
psychological struggles that are a part of cancer
recovery. I wanted to express that cancer
treatment is about taking care of the whole person
not just the person’s body.”
Eden Zimny is a local artist and daugher of a colon cancer survivor. 
Her painting is on permanent display in the cancer center.
About our cover
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